Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic N-acetylcysteine for Cisplatin-induced Ototoxicity
NCT04226456Phase 4Terminated
- Sponsor
- Saint-Pierre University Hospital
- Start
- Jul 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of acetylcysteine in ototoxicity (2 arms), sponsored by Saint-Pierre University Hospital. Primary endpoint: Apparition of ototoxicity. Started Jul 2021; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
ototoxicity
Beyond the preview
Go deeper on NCT04226456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04226456.